Euodenine A: A Small-Molecule Agonist of Human TLR4
摘要:
A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.
Euodenine A: A Small-Molecule Agonist of Human TLR4
摘要:
A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.
One-Pot Preparation of Pyranoquinolinones by Ytterbium(III) Trifluoromethanesulfonate-Catalyzed Reactions: Efficient Synthesis of Flindersine, N-Methylflindersine, and Zanthosimuline Natural Products
作者:Yong Rok Lee、Hyuk Il Kweon、Wha Soo Koh、Kyung Rak Min、Youngsoo Kim、Seung Ho Lee
DOI:10.1055/s-2001-17516
日期:——
An efficient synthesis of pyranoquinolinones is achieved by ytterbium(III) triflate-catalyzed reaction of 4-hydroxy-2-quinolones with a variety of α,β-unsaturated aldehydes in moderate yields. This new method has been applied to the synthesis of pyranoquinolinone alkaloids.
Efficient Synthesis of Substituted Pyranoquinolinones from 2,4-Dihydroxyquinoline: Total Synthesis of Zanthosimuline, <b><i>cis</i></b>-3<b>′</b>,4<b>′</b>-Dihydroxy-3<b>′</b>,4<b>′</b>-dihydroflindersine, and Orixalone D
作者:Yong Lee、Xue Wang
DOI:10.1055/s-2007-983893
日期:2007.10
A convenient and efficient synthesis of pyranoquinoli-nones was achieved using the ethylenediamine diacetate catalyzed reactions of 2,4-dihydroxyquinoline and a variety of α,β-unsaturated aldehydes in good yield. The key feature of these reactions is the formal [3+3] cycloaddition. This new methodology was applied successfully to the total synthesis of naturally occurring pyranoquinolinone alkaloids
使用乙二胺二乙酸酯催化的 2,4-二羟基喹啉和多种 α,β-不饱和醛的反应以良好的收率实现了一种方便高效的吡喃喹啉酮合成。这些反应的关键特征是正式的 [3+3] 环加成。这种新方法成功地应用于天然存在的吡喃喹啉酮生物碱、zanthosimuline、CIS-3',4'-dihydroxy-3',4'-dihydroflindersine 和 orixalone D 的全合成。
Euodenine A: A Small-Molecule Agonist of Human TLR4
作者:Juliette E. Neve、Hasanthi P. Wijesekera、Sandra Duffy、Ian D. Jenkins、Justin A. Ripper、Simon J. Teague、Marc Campitelli、Agatha Garavelas、George Nikolakopoulos、Phuc V. Le、Priscila de A. Leone、Ngoc B. Pham、Philip Shelton、Neil Fraser、Anthony R. Carroll、Vicky M. Avery、Christopher McCrae、Nicola Williams、Ronald J. Quinn
DOI:10.1021/jm401321v
日期:2014.2.27
A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.